According to research published in the journal Clinical Cancer Research, the addition of valproate, a histone deacetylase inhibitor, with the traditional combination of pemetrexed and cisplatin may improve the effectiveness of this more common form of treatment [...]" (2009-6-10)
mercredi 10 juin 2009
Mesothelioma Research may Provide Additional Treatment Option
"Research conducted by F. Vandermeers and co-authors has provided insight into a new treatment combination for malignant mesothelioma patients.
According to research published in the journal Clinical Cancer Research, the addition of valproate, a histone deacetylase inhibitor, with the traditional combination of pemetrexed and cisplatin may improve the effectiveness of this more common form of treatment [...]" (2009-6-10)
Read more...
According to research published in the journal Clinical Cancer Research, the addition of valproate, a histone deacetylase inhibitor, with the traditional combination of pemetrexed and cisplatin may improve the effectiveness of this more common form of treatment [...]" (2009-6-10)
